Drug Shortage Report for HYPERTET S/D
| Report ID | 146944 |
| Drug Identification Number | 02230697 |
| Brand name | HYPERTET S/D |
| Common or Proper name | TETANUS IMMUNOGLOBULIN (HUMAN), SOLVENT DETERGENT TREATED |
| Company Name | GRIFOLS THERAPEUTICS LLC |
| Market Status | DORMANT |
| Active Ingredient(s) | TETANUS IMMUNOGLOBULIN |
| Strength(s) | 250UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 250 AU PRE-FILLED SYRINGE |
| ATC code | J06BB |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2021-10-08 |
| Actual start date | |
| Estimated end date | 2021-12-10 |
| Actual end date | 2021-12-10 |
| Shortage status | Resolved |
| Updated date | 2021-12-11 |
| Company comments | Resolved. Grifols was in process of transitioning to HyperTET® produced using an updated manufacturing process that has been approved by Health Canada. Grifols was managing a tight supply to bridge the gap until the new batch was available in Canada early December. Because of limited stock at Grifols Canada, during the transition Grifols was focusing on filling orders that were specific to an immediate patient need, rather than stock replacement. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | GrifolsCanadaMedInfo@grifols.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2021-12-11 | English | Compare |
| v10 | 2021-12-10 | French | Compare |
| v9 | 2021-12-10 | English | Compare |
| v8 | 2021-11-11 | French | Compare |
| v7 | 2021-11-11 | English | Compare |
| v6 | 2021-11-11 | French | Compare |
| v5 | 2021-11-11 | English | Compare |
| v4 | 2021-10-09 | English | Compare |
| v3 | 2021-10-08 | French | Compare |
| v2 | 2021-10-08 | French | Compare |
| v1 | 2021-10-08 | English | Compare |
Showing 1 to 11 of 11